Nang Kuang Pharmaceutical Co., Ltd.

Research Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) on Bullrun: market cap TWD 3.18B, P/E 15.6, dividend yield 5.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 3.18B; P/E is 15.6; dividend yield is 5.1%.

Peer valuation comparison

Latest P/E is 15.59x versus a Healthcare sector median of 21.8x (28.5% below).

Latest dividend yield is 5.12% versus a Healthcare sector median of 2.41% (112.4% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 3.18B15.65.1%1.6

Dividend history

Latest trailing dividend snapshot: annual dividend/share 1.6 TWD, yield 5.1%.

About Nang Kuang Pharmaceutical Co., Ltd.

Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Nang Kuang Pharmaceutical Co., Ltd.'s market cap?

Nang Kuang Pharmaceutical Co., Ltd.'s market capitalization is TWD 3.18B.

What is Nang Kuang Pharmaceutical Co., Ltd.'s P/E ratio?

Nang Kuang Pharmaceutical Co., Ltd.'s price-to-earnings (P/E) ratio is 15.6.

Does Nang Kuang Pharmaceutical Co., Ltd. pay a dividend?

Nang Kuang Pharmaceutical Co., Ltd. has a dividend yield of 5.1%.

What does Nang Kuang Pharmaceutical Co., Ltd. do?

Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion.